mono-pegylated proline interferon

AOP Orphan reports full validity of arbitral award against PharmaEssentia

Dr Rudolf Widmann, Chief Therapeutics Development Officer, Board Member, Founder, AOP Orphan Pharmaceuticals AG. (Copyright: bell&sass) Vienna, Austria:  Today the…

Read More »